Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Arsenic trioxide plus all trans retinoic acid improves QoL and reduces fatigue...

Prof Fabio Efficace - Italian Group for Adult Hematologic Diseases (GIMEMA)...

Arsenic trioxide plus all trans retinoic acid improves QoL and reduces fatigue in high risk acute promyelocytic leukaemia ( Prof Fabio Efficace - Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy )

Pirtobrutinib plus venetoclax rituximab improves PFS in previously treated CLL...

Dr Matthew Davids - Dana-Farber Cancer Institute, Boston, USA

Pirtobrutinib plus venetoclax rituximab improves PFS in previously treated CLL and SLL ( Dr Matthew Davids - Dana-Farber Cancer Institute, Boston, USA )

Subcutaneous blinatumomab plus TKI drives high remission in relapsed Ph+ acute...

Prof Elias Jabbour - The University of Texas MD Anderson Cancer Center, Houston...

Subcutaneous blinatumomab plus TKI drives high remission in relapsed Ph+ acute lymphoblastic leukaemia ( Prof Elias Jabbour - The University of Texas MD Anderson Cancer Center, Houston, USA )

Selinexor plus ruxolitinib improves spleen response and survival in Janus...

Prof Claire Harrison - Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Selinexor plus ruxolitinib improves spleen response and survival in Janus kinase inhibitor naïve myelofibrosis ( Prof Claire Harrison - Guy’s and St Thomas’ NHS Foundation Trust, London, UK )

Fatigue in adult ITP is common despite adequate platelet counts and minimal...

Prof David Kuter - Harvard Medical School, Boston, USA

Fatigue in adult ITP is common despite adequate platelet counts and minimal bleeding ( Prof David Kuter - Harvard Medical School, Boston, USA )

Surovatamig plus rituximab induces high complete response rates in previously...

Prof Chan Cheah - Sir Charles Gairdner Hospital, Perth, Australia

Surovatamig plus rituximab induces high complete response rates in previously untreated follicular lymphoma ( Prof Chan Cheah - Sir Charles Gairdner Hospital, Perth, Australia )

Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in...

Dr Frederick Chen - Barts Health NHS Trust, London, UK

Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in acute ICT in 1L treatment during COVID 19 ( Dr Frederick Chen - Barts Health NHS Trust, London, UK )

Tafasitamab plus lenalidomide added to R-CHOP improves PFS in high-risk diffuse...

Prof Umberto Vitolo - Oncological Institute Candiolo, Turin, Italy

Tafasitamab plus lenalidomide added to R-CHOP improves PFS in high-risk diffuse large B-cell lymphoma ( Prof Umberto Vitolo - Oncological Institute Candiolo, Turin, Italy )

Brentuximab vedotin added to CHEP improves response in CD30+ peripheral T-cell...

Prof Marek Trněný - Charles University, Prague, Czechia

Brentuximab vedotin added to CHEP improves response in CD30+ peripheral T-cell lymphomas ( Prof Marek Trněný - Charles University, Prague, Czechia )

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving...

Prof Martin Schrappe - Universitätsklinikum Schleswig-Holstein, Kiel, Germany

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving survival ( Prof Martin Schrappe - Universitätsklinikum Schleswig-Holstein, Kiel, Germany )

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head &...

Dr Minit Shah - Tata Memorial Centre, Mumbai, India

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer ( Dr Minit Shah - Tata Memorial Centre, Mumbai, India )

Understanding patient expectations and clinicians' goals in favourable risk...

Prof Daniele Santini and Dr Yann Alexandre Vano

Understanding patient expectations and clinicians' goals in favourable risk aRCC patients ( Prof Daniele Santini and Dr Yann Alexandre Vano )

More from ecancer